Close search box Search

Equinox

Equinox International

Meeting consumer demand in a brand new market

Year

2018

Type

NewCo Establishment

Sector

Consumer & Life Sciences

Equinox is a healthcare and consumer business, cultivating medical cannabis in the UK and retailing branded cannabis products, including for flagship brand Mr NICE

Investment Highlights

  • The global cannabis market is forecast to reach over $100 billion by 2030
  • Initially led by North America, legislation initiatives are now passing across Europe and the rest of the world. This provides an opportunity to develop in a newly created industry
  • Kingsley cofounded Equinox International in 2018 to address the demand for medical cannabis. Kingsley plays a central role in the business, providing capital, guidance and operational support
  • Equinox operates solely in federally legal markets, with a Home Office Schedule 1 licence to cultivate medical cannabis at scale in the UK.
  • Equinox's retail brand, "Mr NICE" retails CBD and cannabis accessories across multiple outlets, including in multiple Selfridges stores and Equinox's flagship Mr NICE store in Soho
  • Kingsley also founded the "End Our Pain" lobbying campaign, a key driver in the passing of UK cannabis legislation in 2018

It's great working with the Kingsley team on Equinox. Their business and political network have proved invaluable in opening-up cannabis markets and also helping me grow the company.

Xan Morgan
Cofounder and CEO


Equinox Press Releases

Equinox International